Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Muhammad Umair Mushtaq, Alexandra M. Harrington, Sibgha Gull Chaudhary, Laura C. Michaelis, Karen-Sue B. Carlson, Sameem Abedin, Lyndsey Runass, Natalie S. Callander, Michael J. Fallon, Mark Juckett, Aric C. Hall, Peiman Hematti, Ryan J. Mattison, Ehab L. Atallah & Guru Subramanian Guru Murthy. (2021) Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Leukemia & Lymphoma 62:1, pages 158-166.
Read now
Read now
Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Xuelin Huang, Lianchun Xiao, Guillermo Garcia-Manero, William Plunkett, Varsha Gandhi, Koji Sasaki, Naveen Pemmaraju, Naval G. Daver, Gautam Borthakur, Nitin Jain, Marina Konopleva, Zeev Estrov, Tapan M. Kadia, William G. Wierda, Courtney D. DiNardo, Mark Brandt, Susan M. O’Brien, Jorge E. Cortes & Elias Jabbour. (2018) A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia. Leukemia & Lymphoma 59:4, pages 813-820.
Read now
Read now
Chantal Fridle, Michael Medinger, Matthias C. Wilk, Katja Seipel, Jakob Passweg, Markus G. Manz & Thomas Pabst. (2017) Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leukemia & Lymphoma 58:5, pages 1068-1075.
Read now
Read now
Chun Yew Fong, George Grigoriadis, Jay Hocking, John Coutsouvelis, Jenny Muirhead, Philip Campbell, Eldho Paul, Patricia Walker, Sharon Avery, Sushrut Patil, Andrew Spencer, Anthony Schwarer & Andrew Wei. (2013) Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse. Leukemia & Lymphoma 54:2, pages 336-341.
Read now
Read now
Patricia Hentosh & Dennis M Peffley. (2010) The cladribine conundrum: deciphering the drug's mechanism of action. Expert Opinion on Drug Metabolism & Toxicology 6:1, pages 75-81.
Read now
Read now
Stephen Spurgeon, Margaret Yu, John D Phillips & Elliot M Epner. (2009) Cladribine: not just another purine analogue?. Expert Opinion on Investigational Drugs 18:8, pages 1169-1181.
Read now
Read now
Alice Collier & Gerd
K. Wagner. (2006) Suzuki–Miyaura Cross‐Coupling of Unprotected Halopurine Nucleosides in Water—Influence of Catalyst and Cosolvent. Synthetic Communications 36:24, pages 3713-3721.
Read now
Read now
Felicetto Ferrara, Salvatore Palmieri, Maria Celentano, Mariacarla De Simone, Filiberto Pollio, Maria Rosaria D'Amico, Carolina Copia & Giuseppina Mele. (2006) Feasibility of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia. Leukemia & Lymphoma 47:8, pages 1593-1598.
Read now
Read now
G. Visani, A. Olivieri, M. Malagola, M. Brunori, P. P. Piccaluga, D. Capelli, G. Pomponio, G. Martinelli, A. Isidori, G. Sparaventi & P. Leoni. (2006) Consolidation therapy for adult acute myeloid leukemia: A systematic analysis according to evidence based medicine. Leukemia & Lymphoma 47:6, pages 1091-1102.
Read now
Read now
Anna Korycka & Tadeusz Robak. (2003) The Influence of Imatinib Mesylate (STI571) used alone or in Combination with Purine Nucleoside Analogues on the Normal and Chronic Myelogenous Leukaemia Progenitor Cells In Vitro. Leukemia & Lymphoma 44:9, pages 1549-1555.
Read now
Read now
Articles from other publishers (51)
Xinhong Fei, Weijie Zhang, Jiangying Gu, Fan Yang, Tingting Li, Wenjing Wang & Jingbo Wang. (2023) CLAG combined with total body irradiation as intensive conditioning chemotherapy prior to allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia. Annals of Hematology.
Crossref
Crossref
Jose Tinajero, dat ngo, Alfredo Puing & Paul Koller. (2023) Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with HIV receiving Antiretroviral Therapy: A Single-Center Experience. Acta Haematologica.
Crossref
Crossref
Alberto Monroy-Mora, María de Lourdes Mora-García, Katia Alheli Monroy Mora, Jorge Hernández-Montes, Rosario García-Rocha, Christian Azucena Don-López, Benny Weiss-Steider, Juan José Montesinos-Montesinos & Alberto Monroy-García. (2022) Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells. Cytokine 158, pages 155977.
Crossref
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism
69
105
.
Limei Wu, Srinivas Chatla, Qiqi Lin, Fabliha Ahmed Chowdhury, Werner Geldenhuys & Wei Du. (2021) Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia. Nature Communications 12:1.
Crossref
Crossref
Abel Vieira de Melo Bisneto, Amanda Silva Fernandes, Vivianne de Souza Velozo Sá, Jefferson Hollanda Véras, Estéfane Thaíne Sodré Soares, Aline Ferreira da Silva Santos, Clever Gomes Cardoso, Elisângela de Paula Silveira-Lacerda, Cristiene Costa Carneiro & Lee Chen-Chen. (2021) Anti-angiogenic activity of azathioprine. Microvascular Research 138, pages 104234.
Crossref
Crossref
Marta Libura, Emilia Bialopiotrowicz, Sebastian Giebel, Agnieszka Wierzbowska, Gail J. Roboz, Beata Piatkowska-Jakubas, Marta Pawelczyk, Patryk Gorniak, Katarzyna Borg, Magdalena Wojtas, Izabella Florek, Karolina Matiakowska, Bozena Jazwiec, Iwona Solarska, Monika Noyszewska-Kania, Karolina Piechna, Magdalena Zawada, Sylwia Czekalska, Zoriana Salamanczuk, Karolina Karabin, Katarzyna Wasilewska, Monika Paluszewska, Elzbieta Urbanowska, Justyna Gajkowska-Kulik, Grazyna Semenczuk, Justyna Rybka, Tomasz Wrobel, Anna Ejduk, Dariusz Kata, Sebastian Grosicki, Tadeusz Robak, Agnieszka Pluta, Agata Kominek, Katarzyna Piwocka, Karolina Pyziak, Agnieszka Sroka-Porada, Anna Wrobel, Agnieszka Przybylowicz, Marzena Wojtaszewska, Krzysztof Lewandowski, Lidia Gil, Agnieszka Piekarska, Wanda Knopinska, Lukasz Bolkun, Krzysztof Warzocha, Kazimierz Kuliczkowski, Tomasz Sacha, Grzegorz Basak, Wieslaw Wiktor Jedrzejczak, Jerzy Holowiecki, Przemysław Juszczynski & Olga Haus. (2021) IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen. Scientific Reports 11:1.
Crossref
Crossref
Nadya Jammal, Serena Chew, Farhad Ravandi, Hagop M. Kantarjian & Elias Jabbour. 2021. Acute Leukemias. Acute Leukemias
89
109
.
Sergiu Pasca, Ancuta Jurj, Ciprian Tomuleasa & Mihnea Zdrenghea. (2020) TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia. Medicina 56:12, pages 637.
Crossref
Crossref
Matteo Libero Baroni, Diego Sanchez Martinez, Francisco Gutierrez Aguera, Heleia Roca Ho, Maria Castella, Samanta Zanetti, Talia Velasco Hernandez, Rafael Diaz de la Guardia, Julio Castaño, Eduardo Anguita, Susana Vives, Josep Nomdedeu, Helene Lapillone, Anne E Bras, Vincent H J van der Velden, Jordi Junca, Pedro Marin, Alex Bataller, Jordi Esteve, Binje Vick, Irmela Jeremias, Angel Lopez, Marc Sorigue, Clara Bueno & Pablo Menendez. (2020) 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. Journal for ImmunoTherapy of Cancer 8:1, pages e000845.
Crossref
Crossref
Na Zhang, Jing-Bo Shao, Hong Li, Jing-Wei Yang, Kai Chen, Jia-Shi Zhu & Hui Jiang. (2019) Re-induction with modified CLAG regimen in relapsed or refractory acute myeloid leukemia in children bridging to allogeneic hematopoietic stem cell transplantation. World Journal of Pediatrics 16:2, pages 152-158.
Crossref
Crossref
Hanna Krawczyk. (2019) The stilbene derivatives, nucleosides, and nucleosides modified by stilbene derivatives. Bioorganic Chemistry 90, pages 103073.
Crossref
Crossref
Jun Xu, Ting-Ting Lv, Xiao-Fen Zhou, Ying Huang, Dong-Dong Liu & Guo-Lin Yuan. (2018) Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia. Medicine 97:39, pages e12102.
Crossref
Crossref
Y. Bao, J. Zhao & Z.-Z. Li. (2017) Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study. Clinical and Translational Oncology 20:7, pages 870-880.
Crossref
Crossref
Jingbo Wang, Jie Zhao, Xinhong Fei, Yuming Yin, Haoyu Cheng, Weijie Zhang, Jiangying Gu, Fan Yang, Yixin Yang, Song Xue, Zhengqin Tian, Junbao He, Shuqin Zhang & Xiaocan Wang. (2018) A new intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia. Medicine 97:17, pages e0228.
Crossref
Crossref
J. Zhang, Y. Sun, X. Zhang, B. Long, Y. Lu & X. Li. (2018) Treatment of High-Risk Acute Myeloid Leukemia With Cladribine, Cytarabine, Mitoxantrone, and Granulocyte Colony-Stimulating Factor Then Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series. Transplantation Proceedings 50:1, pages 246-249.
Crossref
Crossref
Małgorzata Patejko, Wiktoria Struck-Lewicka, Danuta Siluk, Małgorzata Waszczuk-Jankowska & Michał J. Markuszewski. 2018.
1
51
.
Elias Jabbour, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Lianchun Xiao, Guillermo Garcia-Manero, William Plunkett, Varsha Gandhi, Koji Sasaki, Naveen Pemmaraju, Naval G. Daver, Gautam Borthakur, Nitin Jain, Marina Konopleva, Zeev Estrov, Tapan M. Kadia, William G. Wierda, Courtney D. DiNardo, Mark Brandt, Susan M. O'Brien, Jorge E. Cortes & Hagop Kantarjian. (2017) A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia. Cancer 123:22, pages 4430-4439.
Crossref
Crossref
Nicholas J. Short & Farhad Ravandi. (2016) Acute Myeloid Leukemia: Past, Present, and Prospects for the Future. Clinical Lymphoma Myeloma and Leukemia 16, pages S25-S29.
Crossref
Crossref
Marta Libura, Sebastian Giebel, Beata Piatkowska-Jakubas, Marta Pawelczyk, Izabella Florek, Karolina Matiakowska, Bozena Jazwiec, Katarzyna Borg, Iwona Solarska, Magdalena Zawada, Sylwia Czekalska, Jolanta Libura, Malgorzata Jakobczyk, Karolina Karabin, Monika Paluszewska, Malgorzata Calbecka, Justyna Gajkowska-Kulik, Grazyna Gadomska, Marek Kielbinski, Anna Ejduk, Dariusz Kata, Sebastian Grosicki, Agnieszka Wierzbowska, Slawomira Kyrcz-Krzemien, Krzysztof Warzocha, Kazimierz Kuliczkowski, Aleksander Skotnicki, Jerzy Holowiecki, Wieslaw Wiktor Jedrzejczak & Olga Haus. (2016) Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients. Blood 127:3, pages 360-362.
Crossref
Crossref
Lucyna Dymińska. (2015) Imidazopyridines as a source of biological activity and their pharmacological potentials—Infrared and Raman spectroscopic evidence of their content in pharmaceuticals and plant materials. Bioorganic & Medicinal Chemistry 23:18, pages 6087-6099.
Crossref
Crossref
Antoni Cortés, Eduard Gracia, Estefania Moreno, Josefa Mallol, Carme Lluís, Enric I. Canela & Vicent Casadó. (2015) Moonlighting Adenosine Deaminase: A Target Protein for Drug Development. Medicinal Research Reviews 35:1, pages 85-125.
Crossref
Crossref
Michael V. Jaglal, Vu H. Duong, Celeste M. Bello, Najla H. Al Ali, Eric Padron, Hugo F. Fernandez, Alan F. List, Jeffrey E. Lancet & Rami S. Komrokji. (2014) Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure. Leukemia Research 38:4, pages 443-446.
Crossref
Crossref
Pawel Robak & Tadeusz Robak. (2013) Older and new purine nucleoside analogs for patients with acute leukemias. Cancer Treatment Reviews 39:8, pages 851-861.
Crossref
Crossref
Jerzy HolowieckiSebastian GrosickiSebastian GiebelTadeusz RobakSlawomira Kyrcz-KrzemienKazimierz KuliczkowskiAleksander B. SkotnickiAndrzej HellmannKazimierz SulekAnna DmoszynskaJanusz KloczkoWieslaw W. JedrzejczakBarbara ZdziarskaKrzysztof WarzochaKrystyna ZawilskaMieczysław KomarnickiMarek KielbinskiBeata Piatkowska-JakubasAgnieszka WierzbowskaMalgorzata WachOlga Haus. (2012) Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study. Journal of Clinical Oncology 30:20, pages 2441-2448.
Crossref
Crossref
L. Dymińska, A. Gągor, Z. Talik, J. Lorenc & J. Hanuza. (2011) Vibrational spectra and structure of methyl-derivatives of imidazo[4,5-c]pyridine based on DFT quantum chemical calculations and XRD studies. Vibrational Spectroscopy 57:2, pages 229-241.
Crossref
Crossref
Thomas P. Leist & Robert Weissert. (2011) Cladribine. Clinical Neuropharmacology 34:1, pages 28-35.
Crossref
Crossref
Azzurra Romeo, Anna Chierichini, Alessandra Spagnoli, Mariangela Vittori, Michele Vacca, Maria Gozzer, Antonio Spadea, Barbara Anaclerico, Maria Laura Dessanti, Mariella D'Andrea, Giuseppe Toglia, Luciana Annino, Maria Concetta Petti, Andrea Mengarelli & William Arcese. (2010) Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. Transfusion 50:11, pages 2432-2446.
Crossref
Crossref
Ewa Lech-Maranda, Marek Seweryn, Sebastian Giebel, Jerzy Holowiecki, Beata Piatkowska-Jakubas, Joanna Wegrzyn, Aleksander Skotnicki, Marek Kielbinski, Kazimierz Kuliczkowski, Monika Paluszewska, Wieslaw Wiktor Jedrzejczak, Magdalena Dutka, Andrzej Hellmann, Marcin Flont, Barbara Zdziarska, Grazyna Palynyczko, Lech Konopka, Tomasz Szpila, Krzysztof Gawronski, Kazimierz Sulek, Jaroslaw Sokolowski, Janusz Kloczko, Krzysztof Warzocha & Tadeusz Robak. (2010) Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG). International Journal of Infectious Diseases 14:2, pages e132-e140.
Crossref
Crossref
Tadeusz Robak & Agnieszka Wierzbowska. (2009) Current and emerging therapies for acute myeloid leukemia. Clinical Therapeutics 31, pages 2349-2370.
Crossref
Crossref
Henry Ogbomo, Martin Michaelis, Denise Klassert, Hans Wilhelm Doerr & Jindrich CinatlJrJr. (2008) Resistance to Cytarabine Induces the Up-regulation of NKG2D Ligands and Enhances Natural Killer Cell Lysis of Leukemic Cells. Neoplasia 10:12, pages 1402-1410.
Crossref
Crossref
Marcelo de Campos-Nebel, Irene Larripa & Marcela González-Cid. (2008) Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 646:1-2, pages 8-16.
Crossref
Crossref
J. Trotman, P. Presgrave, Y. Kwan, C. Tiley, J. Estell, A. M. Watson, T. A. O’Brien & D. Peters. (2008) Consensus guidelines for ‘rainy day’ autologous stem cell harvests in New South Wales. Internal Medicine Journal 38:4, pages 229-234.
Crossref
Crossref
Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta, Ewa Wawrzyniak, Barbara Cebula, Jerzy Hołowiecki, Sławomira Kyrcz-Krzemień, Sebastian Grosicki, Sebastian Giebel, Aleksander B. Skotnicki, Beata Piątkowska-Jakubas, Kazimierz Kuliczkowski, Marek Kiełbiński, Krystyna Zawilska, Janusz Kłoczko & Agata Wrzesień-Kuś. (2007) Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukem. European Journal of Haematology 80:2, pages 115-126.
Crossref
Crossref
Kazumasa Takenaka, Jessica A. Morgan, George L. Scheffer, Masashi Adachi, Clinton F. Stewart, Daxi Sun, Markos Leggas, Karin F.K. Ejendal, Christine A. Hrycyna & John D. Schuetz. (2007) Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution. Cancer Research 67:14, pages 6965-6972.
Crossref
Crossref
Felicetto Ferrara, Assunta Viola, Carolina Copia, Claudio Falco, Rossella D'Elia, Francesco Paolo Tambaro, Pasqualino Correale, Maria Rosaria D'Amico, Laura Vicari & Salvatore Palmieri. (2007) Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia. Hematological Oncology 25:2, pages 84-89.
Crossref
Crossref
Assunta Viola, Claudio Falco, Rossella D'Elia, Maria R. D'Amico, Laura Vicari, Francesco P. Tambaro, Pasqualino Correale, Daniela Laudati, Salvatore Palmieri & Felicetto Ferrara. (2007) An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia. European Journal of Haematology 78:1, pages 41-47.
Crossref
Crossref
Eric Scholar. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
4
.
Isabelle Hubeek, Gert-Jan L. Kaspers, Gert J. Ossenkoppele & Godefridus J. Peters. 2007. Deoxynucleoside Analogs In Cancer Therapy. Deoxynucleoside Analogs In Cancer Therapy
119
152
.
Zoran Gojkovic & Anna Karlsson. 2007. Deoxynucleoside Analogs In Cancer Therapy. Deoxynucleoside Analogs In Cancer Therapy
403
439
.
J. Holowiecki, S. Grosicki, M. Sadus-Wojciechowska, L. Kachel, A. Hellmann, A. Mital, A.B. Skotnicki, B. Piatkowska-Jakubas, W.W. Jedrzejczak, M. Paluszewska, M. Wach, B. Marianska, A. Wrzesien-Kus, M. Krawczyk-Kulis & J. Wojnar. (2005) Addition of Cladribine to Induction/Consolidation Regimen Does Not Impair Peripheral Blood Stem Cell Mobilization and Bone Marrow Harvest for Autotransplantation in Acute Myeloid Leukemia Patients. Transplantation Proceedings 37:10, pages 4482-4487.
Crossref
Crossref
Tieran Han, Marilyn Fernandez, Ting-Chao Chou & Ram P. Agarwal. (2005) Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells. Journal of Cancer Research and Clinical Oncology 131:9, pages 609-616.
Crossref
Crossref
A. Wrzesień-Kuś, T. Robak, A. Wierzbowska, E. Lech-Marańda, A. Pluta, E. Wawrzyniak, A. Krawczyńska, K. Kuliczkowski, G. Mazur, M. Kiebiński, A. Dmoszyńska, M. Wach, A. Hellmann, W. Baran, J. Hołowiecki, S. Kyrcz-Krzemień & S. Grosicki. (2005) A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group. Annals of Hematology 84:9, pages 557-564.
Crossref
Crossref
Malancha Sarkar, Tieran Han, Vijaya Damaraju, Pat Carpenter, Carol E. Cass & Ram P. Agarwal. (2005) Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. Biochemical Pharmacology 70:3, pages 426-432.
Crossref
Crossref
Tadeusz Robak. (2005) Therapy of Chronic Lymphocytic Leukaemia with Purine Nucleoside Analogues. Drugs & Aging 22:12, pages 983-1012.
Crossref
Crossref
Anna Korycka, Piotr Smolewski & Tadeusz Robak. (2004)
The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors
in vitro
. European Journal of Haematology 73:6, pages 418-426.
Crossref
Crossref
F Ferrara, S Palmieri, M Annunziata, A Viola, B Pocali, C Califano, A M D'Arco & G Mele. (2004) Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation. Bone Marrow Transplantation 34:7, pages 573-576.
Crossref
Crossref
J Holowiecki, S Grosicki, T Robak, S Kyrcz-Krzemien, S Giebel, A Hellmann, A Skotnicki, W W Jedrzejczak, L Konopka, K Kuliczkowski, B Zdziarska, A Dmoszynska, B Marianska, A Pluta, K Zawilska, M Komarnicki, J Kloczko, K Sulek, O Haus, B Stella-Holowiecka, W Baran, B Jakubas, M Paluszewska, A Wierzbowska, M Kielbinski & K Jagoda. (2004) Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia 18:5, pages 989-997.
Crossref
Crossref
Donatella Aldinucci, Dalisa Poletto, Debora Lorenzon, Paola Nanni, Massimo Degan, Karin Olivo, Barbara Rapanà, Antonio Pinto & Valter Gattei. (2004) CD26 Expression Correlates with a Reduced Sensitivity to 2′-Deoxycoformycin-Induced Growth Inhibition and Apoptosis in T-Cell Leukemia/Lymphomas. Clinical Cancer Research 10:2, pages 508-520.
Crossref
Crossref
A. Wrzesień-Kuś, T. Robak, E. Lech-Marańda, A. Wierzbowska, A. Dmoszyńska, M. Kowal, J. Hołowiecki, S. Kyrcz-Krzemień, S. Grosicki, S. Maj, A. Hellmann, A. Skotnicki, W. Je˛drzejczak & K. Kuliczkowski. (2003) A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG). European Journal of Haematology 71:3, pages 155-162.
Crossref
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:2, pages 91-98.
Crossref
Crossref